Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GÜRLER, A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 12 of 12

  • Page / 1
Export

Selection :

  • and

Adhesion molecule expression in erythema nodosum-like lesions in Behçet's disease : A histopathological and immunohistochemical studySENTÜRK, T; AYDINTUG, O; KUZU, I et al.Rheumatology international (Berlin. Print). 1998, Vol 18, Num 2, pp 51-57, issn 0172-8172Article

Long-term effects of interferon alpha 2A treatment in Behçet's diseaseBOYVAT, A; SISMAN-SOLAK, C; GÜRLER, A et al.Dermatology (Basel). 2000, Vol 201, Num 1, pp 40-43, issn 1018-8665Conference Paper

Fibronectin and circulating immune complexes in Behçet's diseaseÖZORAN, K; DÜZGÜN, N; TUTKAK, H et al.Rheumatology international (Berlin. Print). 1996, Vol 15, Num 6, pp 221-224, issn 0172-8172Article

Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's diseaseAYDINTUG, A. O; TOKGÖZ, G; ÖZORAN, K et al.Rheumatology international (Berlin. Print). 1995, Vol 15, Num 2, pp 75-78, issn 0172-8172Article

Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçcet's diseaseÖZORAN, K; DÜZGÜN, N; GÜRLER, A et al.Scandinavian journal of rheumatology. 1995, Vol 24, Num 6, pp 376-382, issn 0300-9742Article

Antibodies to endothelial cells in patients with Behçet's diseaseAYDINTUG, A. O; TOKGÖZ, G; D'CRUZ, D. P et al.Clinical immunology and immunopathology (Print). 1993, Vol 67, Num 2, pp 157-162, issn 0090-1229Article

Factor V Leiden mutation in patients with Behçet's diseaseÖNER, A. F; GÜRGEY, A; GÜRLER, A et al.Journal of rheumatology. 1998, Vol 25, Num 3, pp 496-498, issn 0315-162XArticle

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activityTURAN, B; GALLATI, H; ERDI, H et al.Journal of rheumatology. 1997, Vol 24, Num 1, pp 128-132, issn 0315-162XConference Paper

Urological evaluation of Behçet patients and the effect of colchicine on fertilitySARICA, K; SÜZER, O; GÜRLER, A et al.European urology. 1995, Vol 27, Num 1, pp 39-42, issn 0302-2838Article

FACTORS INFLUENCING TO FORMATION OF TINEA CAPITIS PROFUNDUS KERION CELSIERBAKAN N; NUR OR A; PALALI Z et al.1975; MYKOSEN; DTSCH.; DA. 1975; VOL. 18; NO 1; PP. 35-43; ABS. ALLEM.; BIBL. 28REF.Article

Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's diseaseKAYA, T. I; TURSEN, U; GURLER, A et al.Clinical and experimental dermatology (Print). 2002, Vol 27, Num 6, pp 498-501, issn 0307-6938, 4 p.Article

THE EPIDEMIOLOGY OF SCABIES IN TURKEYTUZUN Y; KOTOGYAN A; CENESIZOGLU E et al.1980; INTERNATION. J. DERMATOL.; USA; DA. 1980; VOL. 19; NO 1; PP. 41-44; BIBL. 7 REF.Article

  • Page / 1